The failure of the ACCLAIM trial is due to an irrational technology

Por Administrator
en 31 Enero 2015

Added by

gregorcuba

Item Type

Journal Article

Title

The failure of the ACCLAIM trial is due to an irrational technology

Author

Bocci, V

Abstract

The excessive blood oxidation devised with the Celacade System does not procure any advantage in chronic heart failure's patients. The irrationality of the procedure delays a therapeutic advantage and ought to be fully revised.

Publication

International Journal of Cardiology

Volume

139

Pages

304-305

Date

2010

URL

http://www.internationaljournalofcardiology.com/article/S0167-5273%2808%2901049-8/abstract

Tags

 

 

 

Ver artículo en ventana emergente

Leave your comments

Post comment as a guest

0
terms and conditions.

Comments

Arriba